Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Biovideo: Endologix Powerlink Endograft

Search BioVideo: 
BioVideo Home Page Promote your Video
New Videos Most Viewed



Try these searches:


Launch in external player

Keywords: Endologix

Source Link

This video has been viewed 1420 times on Bioportfolio.

Recent Search Terms used to find this page: endolo | endologix | endologix | endologics endograft | endologix | endologics endograft | endologix AAA endo graft | endologix | endologics endograft | endolog | .

Description:

Four-Year Results of the Pivotal U.S. Multicenter Trial of the Endologix Powerlink Endograft for EVAR, Presented by Rodney A. White, M.D, at the International Congress XIX on Endovascular Interventions, Scottsdale, AZ, February, 15, 2006.

Endologix

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA.

Related Videos:

*. Contact Peter Barfoot at Bioportfolio using the details below to discuss promoting your videos here.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.